carprofen and 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide

carprofen has been researched along with 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Argyle, DJ; Argyle, SA; Kamida, A; Morrison, KO; Pang, LY1
Becskei, C; Chaudhry, Y; Payne-Johnson, M; Stegemann, MR1

Trials

1 trial(s) available for carprofen and 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide

ArticleYear
Comparative efficacy and safety of mavacoxib and carprofen in the treatment of canine osteoarthritis.
    The Veterinary record, 2015, Mar-14, Volume: 176, Issue:11

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Double-Blind Method; Female; Inflammation; Male; Osteoarthritis; Pain; Pyrazoles; Treatment Outcome

2015

Other Studies

1 other study(ies) available for carprofen and 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide

ArticleYear
The long-acting COX-2 inhibitor mavacoxib (Trocoxilâ„¢) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro.
    BMC veterinary research, 2014, Sep-05, Volume: 10

    Topics: Animals; Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Dogs; Neoplasm Invasiveness; Neoplastic Stem Cells; Pyrazoles

2014